Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Grand Valley Oncology
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ann M Wierman MD LTD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
mi
from
Melrose Park, IL
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Bon Secours DePaul Medical Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Ontario
mi
from
Ontario, CA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascension Saint Mary's Hospital
mi
from
Saginaw, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Smilow Cancer Hospital-Torrington Care Center
mi
from
Torrington, CT
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Maywood
mi
from
Maywood, IL
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Springfield
mi
from
Springfield, VA
Click here to add this to my saved trials
Musculoskeletal, Rheumatology Clinical Trial
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Preferred Pediatrics
mi
from
Lafayette, IN
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sarah Cannon Research Institute at Health One
mi
from
Denver, CO
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Iowa Hospitals and Clinics Pulmonary Hypertension Program
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lovelace Radiation Oncology
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwest Wisconsin Cancer Center
mi
from
Ashland, WI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McLaren Cancer Institute-Bay City
mi
from
Bay City, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Main Line Health Center-Collegeville
mi
from
Collegeville, PA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Tidelands Georgetown Memorial Hospital
mi
from
Georgetown, SC
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Health Care Germantown Health Center
mi
from
Germantown, WI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Franciscan Health Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
X-linked Myotubular Myopathy Clinical Trial
Gene Transfer Clinical Study in X-Linked Myotubular Myopathy
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Powell Center for Rare Disease Research, Univ. of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Hip Fractures Clinical Trial
HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Centre
mi
from
Washington, MA
Click here to add this to my saved trials
Rheumatology Clinical Trial
Clinical Evaluation of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement (CADENCE)
Status: Enrolling
Updated: 12/31/1969
Catholic Health Initiatives
mi
from
Seattle, WA
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
Status: Enrolling, Phase I, II
Updated: 11/29/2017
Farmington Hills, Michigan
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal Clinical Trial
Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Elion & Volhard Pharmaceutical Research (E&V PR)
mi
from
Miami, FL
Click here to add this to my saved trials
Hemophilia A, Congenital Clinical Trial
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Status: Enrolling, Phase
Updated: 12/31/1969
Comprehensive Center for Bleeding Disorders / Blood Center of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hemophilia A, Congenital Clinical Trial
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Multiple Locations,
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Pancreas Cancer Clinical Trial
Azacitidine and Pembrolizumab in Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Columbia University Irving Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
Status: Enrolling
Updated: 12/31/1969
Washington Heights Chest Center
mi
from
New York, NY
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Thomas Jefferson University, Sidney Kimmel Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
Status: Enrolling, Phase IV
Updated: 12/31/1969
Wisdom Clinical Research Institute, Corp.
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
Status: Enrolling, Phase IV
Updated: 12/31/1969
ASCLEPES Research Center
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Insomnia Clinical Trial
Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia
Status: Enrolling
Updated: 8/31/2017
University of Arizona (Banner University Medical Center - Tucson & Banner University Medical Center - South)
mi
from
Tucson, AZ
Click here to add this to my saved trials
Veno-occlusive Disease Clinical Trial
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Royal Adelaide Hospital
mi
from
Adelaide,
Click here to add this to my saved trials
Veno-occlusive Disease Clinical Trial
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
China Medical University Hospital
mi
from
Taichung,
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)
Status: Enrolling, Phase I
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Lymphoma Clinical Trial
An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Status: Enrolling, Phase II
Updated: 12/31/1969
Sarah Cannon Research Institute: Tennessee Oncology, Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Lymphoma Clinical Trial
An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Status: Enrolling, Phase II
Updated: 12/31/1969
Seattle Cancer Care Alliance (SCCA)
mi
from
Seattle, WA
Click here to add this to my saved trials
Lymphoma Clinical Trial
An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Status: Enrolling, Phase II
Updated: 12/31/1969
Renovatio Clinical
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Contraception Clinical Trial
Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
Status: Enrolling
Updated: 12/31/1969
St. Luke's Hospital- Allentown Campus
mi
from
Allentown, PA
Click here to add this to my saved trials
Contraception Clinical Trial
Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
Status: Enrolling
Updated: 12/31/1969
Seven Hills Women's Health Centers
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Contraception Clinical Trial
Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
Status: Enrolling
Updated: 12/31/1969
Women's Integrated Health Care, PC
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™
Status: Enrolling, Phase III
Updated: 12/31/1969
Vince Lombardi Cancer Center (Aurora St. Luke's Medical Center)
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health- Center for Advanced Medicine
mi
from
Lake Success, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University Cancer Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Lake Huron Medical Center
mi
from
Port Huron, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital South
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Urethral Stricture Clinical Trial
Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease
Status: Enrolling
Updated: 12/31/1969
Chesapeake Urology
mi
from
Hanover, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Other Clinical Trial
Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV
Status: Enrolling, Phase I
Updated: 12/31/1969
Grady Health System (non-CRN), Grady Health System (CRN), Ponce Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Other Clinical Trial
Aging Mastery Program® (AMP) Evaluation
Status: Enrolling
Updated: 12/20/2017
San Pedro Service Center
mi
from
San Pedro, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascendis Pharma Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Status: Enrolling, Phase III
Updated: 12/31/1969
AGA Clinical Research Associates, LLC /ID# 164641
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Status: Enrolling, Phase III
Updated: 12/31/1969
Nola Research Works, LLC /ID# 164612
mi
from
New Orleans, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research /ID# 167765
mi
from
San Pablo, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Washington /ID# 164646
mi
from
Seattle, WA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Delta Waves, Inc. /ID# 164872
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research /ID# 164853
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Louisiana Research Center, LLC /ID# 164659
mi
from
Shreveport, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC /ID# 164823
mi
from
Houma, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Weill Cornell Medicine/NYP /ID# 165504
mi
from
New York, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research /ID# 167767
mi
from
San Pablo, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Tyler Research Institute, LLC /ID# 168687
mi
from
Tyler, TX
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Columbus, GA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials